A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine.
about
A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
A long-term open-label study o ...... e treatment of acute migraine.
@en
A long-term open-label study o ...... e treatment of acute migraine.
@nl
type
label
A long-term open-label study o ...... e treatment of acute migraine.
@en
A long-term open-label study o ...... e treatment of acute migraine.
@nl
prefLabel
A long-term open-label study o ...... e treatment of acute migraine.
@en
A long-term open-label study o ...... e treatment of acute migraine.
@nl
P2860
P1433
P1476
A long-term open-label study o ...... e treatment of acute migraine.
@en
P2093
Ninan T Mathew
Oral Almotriptan Study Group
P2860
P356
10.1046/J.1526-4610.2002.02011.X
P577
2002-01-01T00:00:00Z